Sortino ratio is not yet available for PBPH. This metric requires at least 12 months of historical daily returns to calculate. Check back once this data is available.
How it compares to other similar ETFs
The table compares Portfolio Building Block World Pharma and Biotech Index ETF's Sortino Ratio with other ETFs in the Health & Biotech Equities, Global Equities category across multiple time periods, showing how PBPH's risk-adjusted performance compares to similar funds.
Data shows 1-, 5-, and 10-year periods, plus each fund's all-time average, as of Jun 24, 2026.
| Symbol | Name | 1Y Sortino Ratio | 5Y Sortino Ratio | 10Y Sortino Ratio | All Time Sortino Ratio |
|---|---|---|---|---|---|
| BBC | Virtus LifeSci Biotech Clinical Trials ETF | 4.70 | |||
| WLDR | Affinity World Leaders Equity ETF | 4.52 | |||
| SBIO | ALPS Medical Breakthroughs ETF | 4.09 | |||
| FYLD | Cambria Foreign Shareholder Yield ETF | 4.04 | |||
| IHE | iShares U.S. Pharmaceuticals ETF | 3.95 | |||
| XBI | SPDR S&P Biotech ETF | 3.89 | |||
| FTXH | First Trust Nasdaq Pharmaceuticals ETF | 3.81 | |||
| LFSC | F/m Emerald Life Sciences Innovation ETF | 3.79 | |||
| PJP | Invesco Dynamic Pharmaceuticals ETF | 3.79 | |||
| GVAL | Cambria Global Value ETF | 3.72 | |||
| PBPH | Portfolio Building Block World Pharma and Biotech Index ETF | — |
Historical Sortino Ratio
The chart shows PBPH's rolling Sortino ratio over time compared to your chosen benchmark. Rising trends indicate improving returns relative to downside risk, while declining trends may signal deteriorating risk-adjusted performance or increased volatility during market stress. Use multiple timeframes to distinguish short-term fluctuations from long-term patterns.
Identify market cycles by observing when PBPH consistently outperforms (line above benchmark), underperforms (below benchmark), or aligns with the benchmark.
Loading charts...
IHow does PBPH fit in your portfolio?
Add your other holdings to see your portfolio's Sortino Ratio and find out.
Analyze Your Portfolio